Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Stoke Therapeutics, Inc. (STOK) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $23.53 Metrics
OS: 33.0 M -18 % ROE
Market cap: $776 M -280 % ROIC
Net cash: $211 M $6.41 per share
EV: $565 M

 
TTM Valuation
EBITDA ($40.6) M
EBIT ($41.1) M
EPS ($2.70)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17
Revenues0.00.03.6
            Revenue growth -100.0% 
Cost of goods sold0.00.05.6
Gross profit0.00.0-2.0
            Gross margin  -54.4%
Research and development23.88.4 
General and administrative11.94.42.0
EBIT-35.7-12.8-5.6
            EBIT margin  -154.4%
Pre-tax income-32.3-12.5-5.6
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-32.3-12.5-5.6
            Net margin  -154.5%
 
Diluted EPS($1.80)($17.65)($8.29)
Shares outstanding (diluted)18.00.70.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy